Is there a suitable way to purchase genuine evantumumab?

Introduction: Evantumumab is the first fully human bispecific antibody approved for the treatment of lung cancer. It has been approved by the FDA and has become the first targeted therapy drug for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. Evantumumab is currently not approved in mainland China. If you need to purchase it, you may need to consider purchasing the drug overseas or other methods.

How to purchase genuine evantumumab

1. Hospital pharmacy: is listed in Hong Kong, China, so you can go to a hospital in Hong Kong, China. After the doctor issues a medical prescription, you can purchase evantumumab directly in the hospital pharmacy.

2. Regular pharmacies: You can buy evantumumab in pharmacies in Hong Kong, China, and it is usually available. You can go to large pharmacies to inquire whether you can buy evantumumab.

3. Overseas drug purchase: You can go to countries where evantumumab is already on the market. You may be able to buy the Turkish version or other export versions of evantumumab.

4. Medical institutions: There are some domestic medical service institutions that cooperate with foreign pharmaceutical companies or hospitals and may provide medical services such as global drug search and drug purchase. You can inquire whether you can buy evantumumab.

If you need to purchase evantumumab, it is recommended to consult a professional doctor or medical institution to learn about legal and safe purchasing methods. At the same time, pay attention to the refrigeration requirements and correct dosage of the drug.

The price of evantumumab

The specification of evantumumab produced by Janssen Pharmaceuticals in the United States is 350mg/7ml per box. The reference price of a box is approximately between 10,300$-11,000$. The price may change due to exchange rate changes, different purchasing channels and other factors. It is recommended to refer to the actual price at the time of purchase.

How to administer evantumumab

Evantumumab is a solution that should be injected slowly into a vein by a doctor or nurse at a medical facility or infusion center. Initially, injections are usually given once daily for 2 consecutive days. After the first 2 doses, injections are usually given every 2 weeks until the end of treatment. The length of treatment depends on the body's response to the drug and the side effects experienced.

A doctor or nurse will observe closely during and after the infusion to ensure that the patient does not have a serious reaction to the drug. If symptoms such as nausea, vomiting, shortness of breath, fever, chills, flushing, chest pain, dizziness, etc. occur during the infusion, the doctor or nurse should be informed immediately. The doctor may need to slow down the infusion rate, or interrupt or stop treatment.